• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区外显子组中可采取行动的致病性二级发现的频率和频谱。

Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.

机构信息

College of Medicine, National Taiwan University, Taipei, Taiwan.

Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Mol Genet Genomic Med. 2020 Oct;8(10):e1455. doi: 10.1002/mgg3.1455. Epub 2020 Aug 14.

DOI:10.1002/mgg3.1455
PMID:32794656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7549563/
Abstract

BACKGROUND

Exome sequencing has recently become more readily available, and more information about incidental findings has been disclosed. However, data from East Asia are scarce. We studied the application of exome sequencing to the identification of pathogenic/likely pathogenic variants in the ACMG 59 gene list and the frequency of these variants in the Taiwanese population.

METHODS

This study screened 161 Taiwanese exomes for variants from the ACMG 59 gene list. The identified variants were reviewed based on information from different databases and the available literature and classified according to the ACMG standard guidelines.

RESULTS

We identified seven pathogenic/likely pathogenic variants in eight individuals, with five participants with autosomal recessive variants in one allele and three participants with autosomal dominant variants. Approximately 1.86% (3/161) of the Taiwanese individuals had a reportable pathogenic/likely pathogenic variant as determined by whole-exome sequencing (WES), which was comparable to the proportions published previously in other countries. We further investigated the high carrier rate of rare variants in the ATP7B gene, which might indicate a founder effect in our population.

CONCLUSION

This study was the first to provide Taiwanese population data of incidental findings and emphasized a high carrier rate of candidate pathogenic/likely pathogenic variants in the ATP7B gene.

摘要

背景

外显子组测序技术最近变得更加普及,更多的偶然发现信息也被披露。然而,东亚地区的数据仍然相对较少。本研究旨在探讨外显子组测序技术在识别 ACMG59 基因列表中的致病性/可能致病性变异以及这些变异在台湾人群中的频率方面的应用。

方法

本研究对 161 例台湾人的外显子组进行了 ACMG59 基因列表中的变异筛选。根据不同数据库和现有文献中的信息对鉴定出的变异进行了回顾,并根据 ACMG 标准指南进行了分类。

结果

我们在 8 个人中发现了 7 个致病性/可能致病性变异,其中 5 人在一个等位基因中存在常染色体隐性变异,3 人存在常染色体显性变异。通过全外显子组测序(WES)确定,大约有 1.86%(3/161)的台湾个体存在可报告的致病性/可能致病性变异,这与之前在其他国家发表的比例相当。我们进一步研究了 ATP7B 基因中罕见变异的高携带率,这可能表明在我们的人群中存在一个遗传起源。

结论

本研究首次提供了台湾人群的偶然发现数据,并强调了 ATP7B 基因中候选致病性/可能致病性变异的高携带率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bd/7549563/ea6db27f308e/MGG3-8-e1455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bd/7549563/ea6db27f308e/MGG3-8-e1455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bd/7549563/ea6db27f308e/MGG3-8-e1455-g001.jpg

相似文献

1
Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.台湾地区外显子组中可采取行动的致病性二级发现的频率和频谱。
Mol Genet Genomic Med. 2020 Oct;8(10):e1455. doi: 10.1002/mgg3.1455. Epub 2020 Aug 14.
2
Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.196 个韩国外显子组中可采取行动的致病性二级发现的频率和频谱。
Genet Med. 2015 Dec;17(12):1007-11. doi: 10.1038/gim.2015.26. Epub 2015 Apr 9.
3
Determination of Carrier Frequency of Actionable Pathogenic Variants in Autosomal Recessive Genetic Diseases in the Turkish Cypriot Population.土耳其塞浦路斯人群中常染色体隐性遗传疾病中致病变异体的载频测定。
Genes (Basel). 2023 Oct 20;14(10):1967. doi: 10.3390/genes14101967.
4
Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype.全外显子组测序鉴定出 ATP7B 基因中的新致病变异体和威尔逊病表型的一些修饰因子。
Liver Int. 2019 Jan;39(1):177-186. doi: 10.1111/liv.13967. Epub 2018 Oct 8.
5
Actionable, pathogenic incidental findings in 1,000 participants' exomes.1000 名参与者外显子组中的可操作、致病性偶然发现。
Am J Hum Genet. 2013 Oct 3;93(4):631-40. doi: 10.1016/j.ajhg.2013.08.006. Epub 2013 Sep 19.
6
High-frequency actionable pathogenic exome variants in an average-risk cohort.平均风险队列中的高频可操作致病外显子变异
Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6). doi: 10.1101/mcs.a003178. Print 2018 Dec.
7
Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.1559 个泰国外显子组中 73 个 ACMG 推荐基因的可操作的次要发现。
J Hum Genet. 2022 Mar;67(3):137-142. doi: 10.1038/s10038-021-00982-2. Epub 2021 Oct 8.
8
Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases.功能研究对早发性心脏传导系统疾病外显子组序列变异解读的影响。
Cardiovasc Res. 2020 Nov 1;116(13):2116-2130. doi: 10.1093/cvr/cvaa010.
9
Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi-Bickel Syndrome.全外显子组测序揭示了三名患有VI型糖原贮积病和范科尼-比克综合征患者的新型致病变异及其他发现。
Front Genet. 2021 Jan 11;11:601566. doi: 10.3389/fgene.2020.601566. eCollection 2020.
10
Pathogenic gene variation spectrum and carrier screening for Wilson's disease in Qingdao area.青岛地区 Wilson 病的致病基因突变谱及携带者筛查
Mol Genet Genomic Med. 2021 Aug;9(8):e1741. doi: 10.1002/mgg3.1741. Epub 2021 Jul 9.

引用本文的文献

1
Medically Actionable Secondary Findings from Whole-Exome Sequencing (WES) Data in a Sample of 3972 Individuals.对3972名个体样本的全外显子组测序(WES)数据进行的具有医学可操作性的次要发现
Int J Mol Sci. 2025 Apr 9;26(8):3509. doi: 10.3390/ijms26083509.
2
Secondary findings in hereditary cancer genes after germline genetic testing - systematic review of literature.生殖系基因检测后遗传性癌症基因的次要发现——文献系统综述
Hum Genet. 2025 Apr 28. doi: 10.1007/s00439-025-02746-w.
3
Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants.

本文引用的文献

1
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.使用 ACMG/AMP 序列变异解读框架推荐功能证据 PS3/BS3 标准的应用。
Genome Med. 2019 Dec 31;12(1):3. doi: 10.1186/s13073-019-0690-2.
2
Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients With Severe Illnesses.关键三重外显子组对重症儿科患者的及时决策有好处。
Pediatr Crit Care Med. 2019 Nov;20(11):1021-1026. doi: 10.1097/PCC.0000000000002068.
3
VarSome: the human genomic variant search engine.
对 14392 份全基因组进行分析,结果显示 3.5%的卡塔尔人携带具有医学可操作性的变异。
Eur J Hum Genet. 2024 Nov;32(11):1465-1473. doi: 10.1038/s41431-024-01656-1. Epub 2024 Jul 17.
4
Complete genomic profiles of 1496 Taiwanese reveal curated medical insights.1496名台湾人的完整基因组图谱揭示了精准的医学见解。
J Adv Res. 2024 Dec;66:197-207. doi: 10.1016/j.jare.2023.12.018. Epub 2023 Dec 29.
5
Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts.撒哈拉以南非洲地区非综合征性口腔颌面裂家系中 130 对三体型中的临床可操作性次要发现。
Mol Genet Genomic Med. 2023 Oct;11(10):e2237. doi: 10.1002/mgg3.2237. Epub 2023 Jul 26.
6
The Singapore National Precision Medicine Strategy.新加坡国家精准医学战略。
Nat Genet. 2023 Feb;55(2):178-186. doi: 10.1038/s41588-022-01274-x. Epub 2023 Jan 19.
7
Secondary findings in a large Pakistani cohort tested with whole genome sequencing.大巴基斯坦队列全基因组测序检测的次要发现。
Life Sci Alliance. 2023 Jan 12;6(3). doi: 10.26508/lsa.202201673. Print 2023 Mar.
8
Analysis of clinically relevant variants from ancestrally diverse Asian genomes.分析来自具有亚洲不同祖先背景的基因组中的临床相关变异。
Nat Commun. 2022 Nov 5;13(1):6694. doi: 10.1038/s41467-022-34116-9.
9
Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List.中国人群次要发现的概况:ACMG SF v3.0清单的实践
J Pers Med. 2022 Sep 14;12(9):1503. doi: 10.3390/jpm12091503.
10
Targeted Sequencing of 242 Clinically Important Genes in the Russian Population From the Ivanovo Region.对伊万诺沃地区俄罗斯人群中242个临床重要基因进行靶向测序。
Front Genet. 2021 Oct 7;12:709419. doi: 10.3389/fgene.2021.709419. eCollection 2021.
VarSome:人类基因组变异搜索引擎。
Bioinformatics. 2019 Jun 1;35(11):1978-1980. doi: 10.1093/bioinformatics/bty897.
4
The global prevalence of Wilson disease from next-generation sequencing data.基于下一代测序数据的威尔逊病全球患病率。
Genet Med. 2019 May;21(5):1155-1163. doi: 10.1038/s41436-018-0309-9. Epub 2018 Sep 26.
5
High genetic carrier frequency of Wilson's disease in France: discrepancies with clinical prevalence.法国威尔逊病的高基因携带者频率:与临床患病率的差异
BMC Med Genet. 2018 Aug 10;19(1):143. doi: 10.1186/s12881-018-0660-3.
6
Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar.1005 个来自卡塔尔的全外显子组和基因组中的偶然和具有临床可操作性的遗传变异体。
Mol Genet Genomics. 2018 Aug;293(4):919-929. doi: 10.1007/s00438-018-1431-8. Epub 2018 Mar 20.
7
The ACMG/AMP reputable source criteria for the interpretation of sequence variants.美国医学遗传学与基因组学学会(ACMG)/美国病理学家协会(AMP)关于序列变异解读的可靠来源标准。
Genet Med. 2018 Dec;20(12):1687-1688. doi: 10.1038/gim.2018.42.
8
Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals.基于 2049 人的全基因组参考面板评估日本人群中报道的致病性变异体及其频率。
J Hum Genet. 2018 Feb;63(2):213-230. doi: 10.1038/s10038-017-0347-1. Epub 2017 Dec 1.
9
Actionable secondary findings from whole-genome sequencing of 954 East Asians.954 位东亚人全基因组测序的可操作的次要发现。
Hum Genet. 2018 Jan;137(1):31-37. doi: 10.1007/s00439-017-1852-1. Epub 2017 Nov 11.
10
Findings of a 1303 Korean whole-exome sequencing study.一项 1303 例韩国全外显子组测序研究的结果。
Exp Mol Med. 2017 Jul 14;49(7):e356. doi: 10.1038/emm.2017.142.